AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction

Recruitingn/aAges 18 Years - anyAllNanjing First Hospital, Nanjing Medical University
💬

In plain words

What the trial is, and whether it could suit you

Acute myocardial infarction (AMI) remains a major cause of mortality and morbidity worldwide. Although percutaneous coronary intervention (PCI) combined with guideline-directed medical therapy has substantially improved survival, many patients continue to experience adverse cardiovascular events after revascularization, including recurrent ischemic events, heart failure, and malignant arrhythmias. Therefore, accurate risk stratification after PCI is essential for optimizing clinical management and improving long-term outcomes. However, currently available risk prediction tools are limited by suboptimal predictive performance or restricted clinical accessibility. Cardiac imaging plays a central role in post-AMI evaluation. Echocardiography is routinely recommended after PCI to assess cardiac structure and function and to exclude early mechanical complications. Nevertheless, its ability t

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥18 years * AMI within the previous 4 weeks, including STEMI or NSTEMI * PCI performed for ACS culprit lesion according to current guidelines * Hemodynamically stable * Willingness to undergo multimodal cardiac CT within 7 days after PCI * Willingness to participate in telephone follow-up Exclusion Criteria: * Contraindications to cardiac CT (eGFR \<30 mL/min/1.73 m² or iodine contrast allergy) * Previous coronary artery bypass graft surgery (CABG) * History of heart failure or previous myocardial infarction * Severe arrhythmia or structural heart disease * Poor image quality or missing CT data * Expected survival \<6 months
💊

What it tests

  • Cardiac CT Follow-up and Echocardiographic Follow-up
📍

Where

2 sites
Nanjing First Hospital, Nanjing Medical University, 68 Changle road, Qinhuai District
Nanjing, China
Nanjing First Hospital, Nanjing Medical University, 68 Changle road, Qinhuai District
Nanjing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy